Cancer Associated Retinopathy in Non-Hodgkin’s Lymphoma

Authors

  • Mohammad Muhsin Chisti Karmanos Cancer Institute, Detroit, MI Department of Hematology and Oncology 4100 John R Road, Detroit, MI, USA
  • Alaa Muslimani 1Donayre Cancer Center 711 N Franklin St Ste B Whiteville, NC 28472 (910) 641-8220, USA
  • Hamed Daw Cleveland Clinic Cancer Center 18200 Lorain Ave Cleveland, OH 44111, USA
  • Ishmael Jaiyesimi Oakland University William Beaumont School of Medicine Department of Hematology and Oncology William Beaumont Hospital 3577 W 13 Mile Rd, Suite 202A Royal Oak, MI 48073, USA
  • Justin F. Klamerus Karmanos Cancer Institute, Detroit, MI Department of Hematology and Oncology 4100 John R Road, Detroit, MI, USA

DOI:

https://doi.org/10.15379/2408-9877.2014.01.02.04

Keywords:

CAR, Retinopathy, Lymphoma.

Abstract

Cancer-associated retinopathy (CAR) is an uncommon paraneoplastic retinopathy usually associated with small cell lung carcinoma. To our knowledge, there is no previous report in the English literature of CAR syndrome occurring in lymphoma patients. We describe a rare case of CAR syndrome in a 62-year-old male with non-Hodgkin’s lymphoma (NHL) treated with four doses of intravenous immunoglobulin.

References

Keltner JL, Thirkill CE. Cancer-associated retinopathy vs recoverin-associated retinopathy. Am J Ophthalmol 1998; 126 (2): 296-302.

Grunwald GB, Klein R, Simmonds MA, et al. Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Lancet 1985; 1: 658-661.

Kornguth SE, Klein R, Appen R, et al. Occurrence of anti-retinal ganglion cell antibodies in patients with small carcinoma of the lung. Cancer 1982; 50: 1289-1293.

Peterson K, Gordon K, Heinemann M, et al. the clinical spectrum of ocular lymphoma. Cancer 1993; 72: 843-849.

Verbraeken HE, Hanssens M, Priem H, et al. Ocular non-Hodgkin's lymphoma: a clinical study of nine cases. Br J Opht 1997; 81(1): 31-36.

Coutinho AB, Muccioli C, Martins MC, et al. Extranodal B-cell lymphoma of the uvea: a case report. Can J Opht 2005; 40 (5): 623-626.

Whitcup SM, Desmet MD, Rubin BI, et al. intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 1993; 100: 1399-1406.

Fredrick DR, Char DH, Ljung BM, et al. Solitary intraocular lymphoma as an initial presentation of widespread disease. Arch Opht 1989; 107(3): 395-397.

Strominger MB, Schatz NJ, Glaser JS. Lymphomatous optic neuropathy. Am J Opht 1993; 15; 116(6): 774-776.

El Kettani A, Lamari H, Lahbil D, et al. Bilateral optic neuropathy and non-Hodkin's lymphoma. Bull Soc Belge Opht 2006; (300): 35-39.

Lee LC, Howes EL, Bhisitkul RB. Systemic non-Hodgkin's lymphoma with optic nerve infiltration in a patient with AIDS. Retina 2002; 22(1): 75-79.

Neetens A, Clemens A, van den Ende P, et al. Optic neuritis in non-Hodgkin's lymphoma. Klin Monatsbl Augenheilkd 1992; 200(5): 525-528.

Saga T, Ohno S, Mastsuda H, et al. Ocular involvement by a peripheral T-cell lymphoma. Arch Opht 1984; 102 (3); 399-402.

Matus G, Dicato M, Focan C. Cancer associated retinopathy (CAR). Two clinical cases and review of the literature. Rev Med Liege 2007; 62(3): 166-169.

Sawyer RA, Selhorst JB, Zimmerman LE, et al. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Opht 1976; 181: 606-613.

Thirkill CE; FitzGerald P; Sergott RC; et al. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N Engl J Med 1989: 7; 321(23): 1589-1594.

Polans AS, Witkowska D, Haley TL, et al. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA 1995; 92(20): 9176-9180.

Adamus G, Aptsiauri N, Guy J, et al. the occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopath 1996; 78: 120-129.

Kawamura S, Rhodopsin Phosphorylation as a mechanism of cyclic GMP phosphodiesterase regulation by S-modulin. Nature 1993; 362: 855-857.

Adamus G, Machnicki M, Seigel GM, et al. Apoptotic retinal cell death induced by anti-recoverin autoantibodies of cancer-associated retinopathy. Invest Opht Vis Sci 1997; 38: 283-291.

Ohguro H, Ogawa K, Maeda T, et al. cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Invest Opht Vis Sci 1999; 40(3): 160-167.

Whitcup SM, Vistica BP, Milam AH, et al. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Opht 1998; 126(2): 230-237.

Khan N, Huang JJ, Foster CS. Cancer associated retinopathy: An autoimmune-mediated paraneoplastic syndrome. Semin Opht 2006; 21(3): 135-141.

Maeda T, Maeda A, Maruyama I, et al. Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Opht Vis Sci 2001; 42(3): 705-712.

Hooks JJ, Tso MO, Detrick B. Retinopathies associated with antiretinal antibodies. Clin Diagn Lab Immunol 2001; 8(5): 853-858.

Keltner JL, Thirkill CE, Tyler NK, et al. Management and monitoring of cancer-associated retinopathy. Arch Opht 1992; 110(1): 48-53.

Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Opht 1999; 117(4): 471-477.

Downloads

Published

2014-11-20

Issue

Vol. 1 No. 2 (2014)

Section

Articles

License

Policy for Journals/Articles with Open Access

Authors who publish with this journal agree to the following terms:
    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  1. Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work

Policy for Journals / Manuscript with Paid Access

Authors who publish with this journal agree to the following terms:
    1. Publisher retain copyright .

  1. Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .